Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IBB vs. FBIOX: which is better?

Bottom line

IBB vs FBIOX: the short answer

IBB (iShares Biotechnology ETF) and FBIOX (Biotechnology Portfolio) are quite different portfolios: only about 34% of their top holdings (by weight) are shared.

IBB is cheaper at 0.44% vs 0.62% — a difference of $18 a year per $10,000 invested.

Over five years, FBIOX returned +3.5% a year vs +2.5% for IBB (reporting dates differ).

Updated Nov 19, 2026

IBB vs FBIOX side by side

IBBFBIOX
TypeETFMutual fund
Fund familyiSharesFidelity
CategoryTechnology SectorTechnology Sector
Expense ratio0.44%0.62%
Annual cost per $10k$44$62
10-yr cost on $10k (prospectus)$555$774
Max front loadNone—
12b-1 fee0%0%
1-yr return+28.0%+36.4%
5-yr return (annualized)+2.5%+3.5%
10-yr return (annualized)+4.4%+6.9%
Best quarter+26.8%+33.6%
Worst quarter−22.9%−28.4%
Net assets (fund)$5.9B$5.3B
Number of holdings254215
Portfolio turnover27%45%
Returns as ofDec 31, 2025Apr 30, 2026

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIBBFBIOXDifference
2025+28.0%+36.4%−8.4%
2024−2.4%+7.3%−9.7%
2023+3.6%+10.1%−6.5%
2022−13.6%−15.9%+2.3%
2021+1.0%−12.4%+13.4%
2020+25.9%+38.3%−12.4%
2019+24.8%+36.0%−11.2%
2018−9.1%−10.7%+1.6%
2017+21.2%+27.9%−6.7%
2016−21.5%−23.7%+2.2%

Source: Fund prospectus bar charts

Holdings overlap

9 of IBB's top 25 holdings also appear in FBIOX's top 25.

Shared top holdings
HoldingIBBFBIOX
Gilead Sciences, Inc.7.52%4.82%
Amgen, Inc.7.50%6.53%
Alnylam Pharmaceuticals, Inc.5.68%2.93%
Argenx SE3.15%2.25%
Insmed, Inc.2.95%2.25%
Natera, Inc.2.11%1.41%
Biogen, Inc.2.03%1.26%
Madrigal Pharmaceuticals, Inc.0.92%0.93%
Moderna, Inc.0.88%1.28%

Source: SEC Form N-PORT

IBB top 10

  1. BlackRock Funds III — 13.18%
  2. Vertex Pharmaceuticals, Inc. — 7.66%
  3. Gilead Sciences, Inc. — 7.52%
  4. Amgen, Inc. — 7.50%
  5. Regeneron Pharmaceuticals, Inc. — 5.70%
  6. Alnylam Pharmaceuticals, Inc. — 5.68%
  7. IQVIA Holdings, Inc. — 3.18%
  8. Argenx SE — 3.15%
  9. Insmed, Inc. — 2.95%
  10. Mettler-Toledo International, Inc. — 2.49%

FBIOX top 10

  1. Krystal Biotech Inc — 10.58%
  2. Abbvie Inc — 9.22%
  3. Amgen Inc — 6.53%
  4. Gilead Sciences Inc — 4.82%
  5. Fidelity Revere Street Trust — 3.35%
  6. Alnylam Pharmaceuticals Inc — 2.93%
  7. Praxis Precision Medicines Inc. — 2.47%
  8. Insmed Inc — 2.25%
  9. Argenx Se — 2.25%
  10. Ascendis Pharma A/s — 2.04%

FAQ

What is the difference between IBB and FBIOX?
IBB (iShares Biotechnology ETF) and FBIOX (Biotechnology Portfolio) are quite different portfolios: only about 34% of their top holdings (by weight) are shared. IBB is cheaper at 0.44% vs 0.62% — a difference of $18 a year per $10,000 invested.
Which is cheaper, IBB or FBIOX?
IBB has the lower expense ratio (0.44%).
Should I own both IBB and FBIOX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.